University Prepares COVID-19 Vaccine Trial in South Africa
The South African Ox1Cov-19 Vaccine VIDA-trial developed by Wits University researchers is a first for Africa and one of 268 other candidate vaccines currently being researched and tested round the world. Shabir Madhi, Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, who leads the trial said: "This is a landmark moment for South Africa and Africa at this stage of the Covid-19 pandemic. As we enter winter in South Africa and pressure increases on public hospitals, now more than ever we need a vaccine to prevent infection by Covid-19."
-
South Africa: Questions Over Access As COVID-19 Vaccine Trial Kicks Off
spotlight, 23 June 2020
South African volunteers are about to join the first COVID-19 vaccine trial to be conducted in the country. Read more »
-
South Africa: First COVID-19 Vaccine Trial in SA Begins
SAnews.gov.za, 23 June 2020
The first participants in South Africa's first clinical trial for a vaccine against COVID-19 will be vaccinated this week. Read more »
-
South Africa: University Readies Nation's First COVID-19 Vaccine Trial
News24Wire, 23 June 2020
Wits university announces SA's first Covid-19 vaccine trial, with participants enrolling this week. This comes as the country breaches 100 000 cases of Covid-19. Participants are… Read more »
InFocus
-
As of August 21, 2022, confirmed cases of Covid-19 from 55 African countries reached 12,126,067 while 373,195,217 vaccinations have been administered across ... Read more »
-
Hundreds of cases have been confirmed in Africa, while globally cases of the novel coronavirus have reached hundreds of thousands - here's how far we are in working towards rapid ... Read more »
